Hormone Replacement Therapy - Review of Options

In a recent study, reduced aging discrepancies were observed in postmenopausal women reporting hormone therapy use vs nonusers.

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Astellas Pharma has announced the first dose administration of fezolinetant to manage moderate to severe vasomotor symptoms in breast cancer patients using adjuvant endocrine therapy.

Actress Kim Cattrall discusses her menopause journey and partnership with Tune In To Menopause, an awareness campaign designed to empower women.

A recent study found that women with a shorter reproductive lifespan had increased odds of multimorbidity compared to those with a longer reproductive lifespan, indicating a need to assess reproductive factors to determine high-risk patients.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.